Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France; Equipe Labellisée Ligue Contre le Cancer, Toulouse, France.
Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France; Equipe Labellisée Ligue Contre le Cancer, Toulouse, France.
Trends Cancer. 2020 Jul;6(7):593-604. doi: 10.1016/j.trecan.2020.03.001. Epub 2020 Mar 26.
Over the past decade, it has become apparent that metabolic reprogramming is a key event in tumor progression. The tumor microenvironment (TME) is a source of metabolites for tumor cells. Lipid-filled mature adipocytes are frequently found in proximity to invasive human tumors and release free fatty acids (FFAs) through lipolysis. These FFAs are taken up by tumor cells and used to promote tumor progression by mechanisms that include mitochondrial fatty acid oxidation (FAO). This review discusses recent advances in our understanding of this metabolic symbiosis between adipocytes and cancer cells and underlines the differences in this metabolic crosstalk between the various types of cancer and their localization.
在过去的十年中,代谢重编程已成为肿瘤进展的关键事件,这一点已变得显而易见。肿瘤微环境(TME)是肿瘤细胞代谢物的来源。富含脂质的成熟脂肪细胞经常在侵袭性人类肿瘤附近发现,并通过脂肪分解释放游离脂肪酸(FFAs)。这些 FFAs 被肿瘤细胞摄取,并通过包括线粒体脂肪酸氧化(FAO)在内的机制被用于促进肿瘤进展。本文综述了我们对脂肪细胞与癌细胞之间这种代谢共生关系的最新理解,并强调了不同类型癌症及其定位之间这种代谢串扰的差异。